CIK 0000748592 · Non-accelerated filer<br>Smaller reporting company
Ernexa Therapeutics Inc.
Sign in to watch- Ticker
- ERNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 311103425
- Phone
- (617) 798-6700
- Business address
- 1035 CAMBRIDGE STREET, SUITE 18A, CAMBRIDGE, MA, 02141
- Former names
- Eterna Therapeutics Inc., Brooklyn ImmunoTherapeutics, Inc., NTN BUZZTIME INC, NTN COMMUNICATIONS INC
Securities
- ERNA Common Stock Nasdaq
- ERNAW Warrants Nasdaq
- 4 Open-market buy 10% owner bought 4,831 shares at $2.95 ($14,245)
- 4 Open-market buy 10% owner bought 28,700 shares at an average $2.51 ($71,948)
- 4 Shares withheld for taxes Interim CEO gave up 722 shares (to pay taxes)
- 4 Shares withheld for taxes SVP of Finance gave up 454 shares (to pay taxes)
- 8-K Event Executive or director change
- 4 Open-market buy 10% owner bought 9,002 shares at an average $2.26 ($20,368)
- 4 Open-market buy 10% owner bought 6,800 shares at an average $2.44 ($16,611)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 8-K Event Executive or director change · Regulation FD disclosure
- 4 Open-market sale 10% owner sold 200 shares at an average $2.78 ($555)
- 4 Shares withheld for taxes CFO and EVP gave up 141 shares (to pay taxes)
- 4 Shares withheld for taxes VP of Finance gave up 35 shares (to pay taxes)
- 4 Shares withheld for taxes CEO gave up 241 shares (to pay taxes)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market buy 10% owner bought 8,651 shares at $3.23 ($27,910)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CEO gave up 240 shares (to pay taxes)
- 4 Shares withheld for taxes CFO and EVP gave up 141 shares (to pay taxes)
Page 28 of 77 · 1,525 filings